Gender equity in hemophilia: need for healthcare, familial, and societal advocacy
1 Introduction Hemophilia is an X-linked recessive disorder caused by the deficiency in coagulation factor VIII (FVIII; hemophilia A) or...
Year: 2025
A Journey into Women’s Brain Health Research
In this special International Women's Day interview on the evolution of neurology with a special focus on women's brain health, we...
Roivios and Caresyntax Partner to Revolutionize Renal Care Through Data-Driven Insights
NASSAU, Bahamas and SAN FRANCISCO, Jan. 9, 2025 /PRNewswire/ -- Roivios, a clinical-stage medical device company, and Caresyntax, a global...
Lancet study has hope for liver cancer: Immunotherapy drug can delay progression in patients who can’t be treated with surgery | Health and Wellness News
Immunotherapy, a form of treatment that uses the body’s immune system to find and fight cancer cells, can delay the...
Liver Cirrhosis Treatment Market: Therapeutic Approaches
IntroductionLiver cirrhosis, a progressive liver disease caused by long-term damage to the liver tissue, remains one of the leading causes...
UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia B
Anette von Drygalski, MD, PharmD, is the director of the Center for Bleeding and Clotting Disorders at UC San Diego...
